Becton, Dickinson and Company BDX Return on equity

Return on equity at other companies

AbbottABT

10.7%-20.4pp

Baxter InternationalBAX

-16.7%-76.7pp

Bio-Rad LaboratoriesBIO

2.5%+1.3pp

TFX

TeleflexTFX

-28.1%-31.6pp

Thermo Fisher ScientificTMO

13.5%+0.1pp

West Pharmaceutical ServicesWST

19.1%+1.4pp

FAQ

What is Becton, Dickinson and Company's return on equity?

Becton, Dickinson and Company (BDX) reported return on equity of 4.6% in Q1 2026.

How has Becton, Dickinson and Company's return on equity changed year-over-year?

Becton, Dickinson and Company's return on equity decreased by 21.7% year-over-year, from 5.9% to 4.6%.

What is the long-term trend for Becton, Dickinson and Company's return on equity?

Over 4 years (2021 to 2025), Becton, Dickinson and Company's return on equity has grown at a -7.2% compound annual growth rate (CAGR), from 8.8% to 6.5%.

What does return on equity mean?

Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.